Skip to main content
Clinical Trials/NCT00004475
NCT00004475
Completed
Not Applicable

Molecular Genetics of Hereditary Pancreatitis

University of Pittsburgh1 site in 1 country808 target enrollmentDecember 1998
ConditionsPancreatitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatitis
Sponsor
University of Pittsburgh
Enrollment
808
Locations
1
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to establish linkage in families with hereditary pancreatitis (HP) to the cationic trypsinogen gene or other, as yet unknown, HP gene(s).

Detailed Description

Hereditary Pancreatitis (HP) is an inflammatory condition of the pancreas which is usually recurrent in nature and occurs in blood-related persons over two or more generations. It is an autosomal dominant trait with complete penetrance by variable expression. Symptoms are usually present during childhood and it is the second most common cause of chronic or recurrent pancreatitis in children. HP is a primary disorder and can therefore be differentiated from other inherited disorders that cause secondary pancreatitis. The purpose of this study is to establish linkage in families with HP between the phenotype and a chromosomal locus (loci) which contains the responsible gene. Affected families are recruited to donate a blood sample through referral from their primary physician or self-referral. The potential significance lies in the identification of the genetic defect causing HP and understanding the pathophysiologic mechanism of the disease. Typically families with HP have a high incidence of adenocarcinoma of the pancreas and identification of the cause of this disease may provide critical insights into the cause of pancreatic cancer. Blood samples are collected from patients and family members. DNA is extracted from the blood and used for genotypic analysis and linkage analysis. Patients do not necessarily receive the results of the genetic testing and the results do not influence the type or duration of treatment.

Registry
clinicaltrials.gov
Start Date
December 1998
End Date
December 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Whitcomb

Principal Investigator

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of pancreatitis at age \< 60 OR
  • Diagnosis of pancreatitis at any age and at least one other 1st or 2nd degree relative with a diagnosis of pancreatitis or pancreatic cancer OR
  • Diagnosis of pancreatic cancer and a 1st or 2nd degree relative with pancreatic cancer or pancreatitis OR
  • Diagnosis of pancreatic insufficiency or maldigestion that improves with pancreatic enzyme replacement OR
  • Close family members (parents, grandparents, siblings cousins - anyone related by blood) of subjects who meet criteria 1, 2, or 3 AND
  • Age 3 months up to 100 years

Exclusion Criteria

  • There are no general exclusions.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials